cadmium has been researched along with Movement Disorders in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dhuriya, YK; Gupta, R; Khanna, VK; Pandey, A; Pant, AB; Sharma, T; Shukla, RK; Siddiqi, MI; Singh, MP; Srivastava, P | 1 |
1 other study(ies) available for cadmium and Movement Disorders
Article | Year |
---|---|
Involvement of PKA/DARPP-32/PP1α and β- arrestin/Akt/GSK-3β Signaling in Cadmium-Induced DA-D2 Receptor-Mediated Motor Dysfunctions: Protective Role of Quercetin.
Topics: Animals; Antioxidants; beta-Arrestins; Cadmium; Corpus Striatum; Cyclic AMP-Dependent Protein Kinases; Dopamine; Dopamine and cAMP-Regulated Phosphoprotein 32; Glycogen Synthase Kinase 3 beta; Male; Movement Disorders; PC12 Cells; Protein Phosphatase 1; Proto-Oncogene Proteins c-akt; Quercetin; Rats; Rats, Wistar; Receptors, Dopamine D2; Signal Transduction; Synapses; Synaptic Transmission | 2018 |